MEIP

MEI Pharma (MEIP)

MEI Pharma Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:MEIP

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/22	05:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MEIP	MEI Pharma Inc
2024/05/22	02:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MEIP	MEI Pharma Inc
2024/05/21	05:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MEIP	MEI Pharma Inc
2024/05/10	05:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MEIP	MEI Pharma Inc
2024/05/10	05:02	Business Wire	MEI Pharma Reports Third Quarter Fiscal Year 2024 Results and Operational Highlights	NASDAQ:MEIP	MEI Pharma Inc
2024/05/10	05:00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:MEIP	MEI Pharma Inc
2024/04/11	21:02	Business Wire	MEI Pharma Board of Directors Aligns on Strategy to Advance Voruciclib and ME-344	NASDAQ:MEIP	MEI Pharma Inc
2024/04/11	21:00	Business Wire	MEI Pharma Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (Avastin®) in Relapsed Metastatic Colorectal Cancer Patients	NASDAQ:MEIP	MEI Pharma Inc
2024/04/10	21:00	Business Wire	MEI Pharma to Present at the Stifel 2024 Virtual Targeted Oncology Forum	NASDAQ:MEIP	MEI Pharma Inc
2024/03/26	21:00	Business Wire	MEI Pharma Reports Update from Clinical Study Evaluating Oral CDK9 Inhibitor Voruciclib in Combination with Venetoclax in Patients with Relapsed and Refractory Acute Myeloid Leukemia	NASDAQ:MEIP	MEI Pharma Inc
2024/02/29	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:MEIP	MEI Pharma Inc
2024/02/22	06:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MEIP	MEI Pharma Inc
2024/02/21	07:33	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:MEIP	MEI Pharma Inc
2024/02/14	07:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MEIP	MEI Pharma Inc
2024/02/14	07:05	Business Wire	MEI Pharma Reports Second Quarter Fiscal Year 2024 Results and Operational Highlights	NASDAQ:MEIP	MEI Pharma Inc
2024/01/18	06:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MEIP	MEI Pharma Inc
2024/01/17	07:00	Business Wire	MEI Pharma to Present Design of Ongoing Clinical Study Evaluating ME-344 at ASCO GI Cancers Symposium 2024	NASDAQ:MEIP	MEI Pharma Inc
2024/01/13	06:00	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	NASDAQ:MEIP	MEI Pharma Inc
2024/01/13	06:00	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	NASDAQ:MEIP	MEI Pharma Inc
2023/12/27	07:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MEIP	MEI Pharma Inc
2023/12/23	06:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MEIP	MEI Pharma Inc
2023/12/21	11:26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MEIP	MEI Pharma Inc
2023/12/21	11:25	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MEIP	MEI Pharma Inc
2023/12/19	06:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MEIP	MEI Pharma Inc
2023/12/12	06:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MEIP	MEI Pharma Inc
2023/12/12	02:00	Business Wire	MEI Pharma Reports Clinical Data on Oral CDK9 Inhibitor Voruciclib at ASH2023	NASDAQ:MEIP	MEI Pharma Inc
2023/11/15	10:59	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:MEIP	MEI Pharma Inc
2023/11/10	06:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MEIP	MEI Pharma Inc
2023/11/10	06:05	Business Wire	MEI Pharma Reports First Quarter Fiscal Year 2024 Results and Operational Highlights	NASDAQ:MEIP	MEI Pharma Inc
2023/11/10	06:00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:MEIP	MEI Pharma Inc